Catalyst Wire Dossier Catalyst Wire Dossier

Aliskiren (SPP100)

aliskiren · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aliskiren (SPP100), covering 2012-04-02 to 2012-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects [Phase 1]

See pricing